SG Americas Securities
TNGX icon

SG Americas Securities’s Tango Therapeutics TNGX Stock Holding History

SG Americas Securities’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
42,659
+18,402
+76% +$455K ﹤0.01% 1705
2026
Q1 		$507K Buy
24,257
+2,251
+10% +$31.3K ﹤0.01% 2178
2025
Q4 		$195K Buy
+22,006
New +$190K ﹤0.01% 2939
2025
Q2 		– Sell
-17,029
Closed -$23K – 3589
2025
Q1 		$23K Sell
17,029
-4,934
-22% -$12.1K ﹤0.01% 3367
2024
Q4 		$68K Buy
21,963
+2,319
+12% +$10.8K ﹤0.01% 2847
2024
Q3 		$151K Buy
+19,644
New +$187K ﹤0.01% 2731
2024
Q2 		– Sell
-30,429
Closed -$242K – 3307
2024
Q1 		$242K Buy
30,429
+4,203
+16% +$45.1K ﹤0.01% 1846
2023
Q4 		$260K Buy
26,226
+5,573
+27% +$48.4K ﹤0.01% 1940
2023
Q3 		$233K Buy
+20,653
New +$126K ﹤0.01% 2223
2023
Q2 		– Sell
-22,444
Closed -$89K – 3152
2023
Q1 		$89K Buy
22,444
+3,978
+22% +$23.1K ﹤0.01% 2950
2022
Q4 		$134K Sell
18,466
-4,278
-19% -$30.1K ﹤0.01% 2513
2022
Q3 		$82K Buy
22,744
+5,633
+33% +$24.1K ﹤0.01% 2904
2022
Q2 		$78K Buy
+17,111
New +$104K ﹤0.01% 3194

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SG Americas Securities's TNGX Position: Q2 2026 in Review

SG Americas Securities increased its Tango Therapeutics (TNGX) stake by 76% in Q2 2026, buying an estimated $455K and bringing the position to 42,659 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

SG Americas Securities first reported a position in TNGX in Q2 2022 and has held it in 13 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • SG Americas Securities held 42,659 shares of Tango Therapeutics worth $1.33M as of Q2 2026.
  • SG Americas Securities bought 18,402 Tango Therapeutics shares in Q2 2026, an estimated $455K.
  • Tango Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1705 holding.
  • SG Americas Securities first reported a position in Tango Therapeutics in Q2 2022 and has held it in 13 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.